Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...

New research shows a common over-the-counter drug may have significant benefits for people with colon and rectal cancer.

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients ...

Research highlights aspirin’s potential in lowering tumor return by 50% in patients with specific genetic mutations - Anadolu ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic mutation, study finds.

A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of ...

Scientists have demonstrated that a common blood thinner is more effective than aspirin—and just as safe—for patients with ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

Early P2Y12 monotherapy after PCI for acute coronary syndrome was not noninferior compared with dual antiplatelet therapy ...

Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes ...